Collegium Pharmaceutical, Inc. (COLL)
Collegium Pharmaceutical Market Cap: 1.464B for Dec. 31, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 2.867B |
| Intuitive Surgical, Inc. | 200.84B |
| Alnylam Pharmaceuticals, Inc. | 52.54B |
| Altimmune, Inc. | 376.15M |
| Vertex Pharmaceuticals, Inc. | 115.03B |
Market Cap Related Metrics
| PE Ratio | 28.83 |
| PS Ratio | 2.317 |
| Price to Book Value | 5.328 |
| Price to Free Cash Flow | 6.063 |
| Price | 46.32 |
| Earnings Yield | 3.47% |
| Operating PE Ratio | 10.79 |
| Normalized PE Ratio | 27.07 |